Rxivist logo

Eicosanoid Inflammatory Mediators Are Robustly Associated with Blood Pressure in the General Population

By Joonatan Palmu, Jeramie D. Watrous, Kysha Mercader, Aki S. Havulinna, Kim A. Lagerborg, Aaro Salosensaari, Mike Inouye, Martin G. Larson, Jian Rong, Ramachandran S Vasan, Leo Lahti, Allen Andres, Susan Cheng, Pekka Jousilahti, Veikko Salomaa, Mohit Jain, Teemu J. Niiranen

Posted 11 Feb 2020
medRxiv DOI: 10.1101/2020.02.08.20021022

BackgroundEpidemiologic and animal studies have associated systemic inflammation with blood pressure (BP). However, the mechanistic factors linking inflammation and BP remain unknown. Fatty acid derived eicosanoids serve as mediators of inflammation and have been suggested to also regulate renal vascular tone, peripheral resistance, renin-angiotensin system, and endothelial function. We therefore hypothesize that specific pro- and anti-inflammatory eicosanoids modulate BP. MethodsIn N=8099 FINRISK 2002 cohort participants randomly drawn from the Finnish population register (53% women, mean age 48{+/-}13 years), we profiled 545 distinct high-quality eicosanoids and related oxylipin mediators in plasma using non-targeted liquid chromatography-mass spectrometry. In models adjusted for conventional hypertension risk factors, we analyzed the associations of eicosanoids and eicosanoid profiles with systolic BP and hypertension. We used the Framingham Heart Study (FHS) Offspring study (N=2859) as the replication cohort. ResultsWe observed 187 eicosanoids (34%) significantly associated with systolic BP (P < Bonferroni-corrected threshold of 0.05/545). 175 of these associations were positive and 12 were negative. Due to strong correlations between the eicosanoids, we used forward selection linear regression modeling to identify six eicosanoids independently related to systolic BP. A risk score based on these six eicosanoids was related to 40% (95% confidence interval [CI], 33-48%) and 32% (95% CI, 21-44%) greater odds of hypertension in FINRISK and FHS, respectively, per 1-SD score increase. Individuals in the upper quartile of the six-eicosanoid risk score had 2.26-fold greater odds (95% CI, 1.96-2.62) of prevalent hypertension in FINRISK, compared with those in the lowest quartile. These findings were successfully replicated in an independent cohort of FHS participants. ConclusionsPlasma eicosanoids demonstrate strong associations with BP in the general population. Intriguingly, we observed specific protective molecules as well as harmful molecules. As eicosanoid compounds affect numerous physiological processes that are central to BP regulation, they may offer new insights regarding pathogenesis of hypertension, as well as serve as new targets for therapeutic intervention.

Download data

  • Downloaded 365 times
  • Download rankings, all-time:
    • Site-wide: 68,131
    • In cardiovascular medicine: 103
  • Year to date:
    • Site-wide: 80,892
  • Since beginning of last month:
    • Site-wide: 80,892

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)